The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Development of skin rash within the 1st week is a potential surrogate marker of therapeutic effect in afatinib monotherapy in patients with EGFR-mt non-small-cell lung cancer (NSCLC): Okayama Lung Cancer Study Group Experience.
 
Kenichiro Kudo
No Relationships to Disclose
 
Katsuyuki Hotta
Travel, Accommodations, Expenses - AstraZeneca
 
Akihiro Bessho
No Relationships to Disclose
 
Naoyuki Nogami
No Relationships to Disclose
 
Toshiyuki Kozuki
Honoraria - AstraZeneca; Chugai Pharma; Kyowa Hakko Kirin; Lilly; Roche Pharma AG; Sanofi; Taiho Pharmaceutical
 
Shoichi Kuyama
Honoraria - Boehringer Ingelheim; Chugai Pharma; Pfizer
 
Koji Inoue
No Relationships to Disclose
 
Shingo Harita
No Relationships to Disclose
 
Toshiaki Okada
No Relationships to Disclose
 
Kenichi Genba
No Relationships to Disclose
 
Masanori Fujii
No Relationships to Disclose
 
Naohiro Oda
Honoraria - Lilly Japan
 
Mitsune Tanimoto
No Relationships to Disclose
 
Katsuyuki Kiura
No Relationships to Disclose